FDA Inspection 1020034 — SUCO, Inc.

SUCO, Inc. — FEI 3001701624

The FDA completed an inspection of SUCO, Inc. on August 2, 2017 in Silver Spring, MD. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 2, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Silver Spring, MD (United States)

Citations

IDCFRDescription
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
136121 CFR 211.100(a)Absence of Written Procedures
139521 CFR 211.103Actual vs. theoretical yields not determined
184221 CFR 211.84(d)(1)Component identity verification
201221 CFR 211.188(b)Batch production and Batch Control Record Requirements